Found 161 matching trials
A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS
PHASE4We hypothesized that a portion controlled diet would prevent the weight gai...
Location
Pennington Center
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics
PHASE3The purpose of this study is to evaluate if type 2 diabetics who have inade...
Location
Local Institution
Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)
PHASE3This study will examine the safety and efficacy of the addition of sitaglip...
Location
Multiple Locations
An Extension Study of PEAK Trial
PHASE4Double blind, three arm, comparative intervention trial for 24 weeks(PEAK s...
Location
Seoul St Mary's Hospital, The Catholic University of Korea
Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 Diabetes
PHASE2The study tests whether pioglitazone (PIO)as compared to metformin (MET)aff...
Location
Center of Excellence for Osteoporosis Research, King Abdulaziz University
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator
PHASE2This is a 24 week study comparing the efficacy of four dose levels of INT13...
Location
Northern California Research
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
PHASE4This study aims to investigate the link between the Ataxia Telangiectasia M...
Location
Ninewells Hospital
Medication in Early Diabetes (MED) Study
PHASE4This study compares metformin (current first-line medication) to pioglitazo...
Location
Menzies School of Health Research
A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
PHASE3The purpose of this clinical research study is to learn if BMS-512148 (Dapa...
Location
Local Institution
Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes
PHASE3Monotherapy with DPP-IV inhibitors, SGLT-2 inhibitors or insulin secretagog...
Location
Nanjing First Hospital, Nanjing Medical Univesity